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Estimating internal exposure or dose of dioxins and related chemicals such as dibenzofurans and
dioxinlike polychlorinated biphenyls is relatively straightforward in laboratory animals because a
known dose is given and the amount absorbed can be measured. In wildlife, direct tissue
measurement and measurement of environmental samples have both recently been used to
estimate exposure. Until recently, human studies used only indirect indicators such as skin
lesions to qualitatively estimate exposure to these chlorinated organic compounds. Environmental
measurements have also sometimes been used to estimate human exposure. Dioxins in human
tissue were not measured until the 1970s, when 2,3,7,8-tetrachlorodibenzo-p-dioxin was
measured in mothers' milk; congener-specific measurement of dioxins and dibenzofurans in
tissues (blood, milk, and adipose tissue) of the general population and exposed workers was first
performed in the United States in the 1980s. Measurement in a sensitive and specific fashion of
the 17 toxic dioxin and dibenzofuran congeners currently found in human tissue from industrial
countries began in the 1980s. The use of known chemical standards, capillary columns, high
resolution gas chromatography and mass spectrometry (GC-MS) has now become relatively
common. GC-MS analysis of blood is currently accepted as the gold standard for estimating
human exposure to dioxins. However, analyses are still costly and time consuming, and
worldwide there are few qualified laboratories. There is currently a lack of knowledge concerning
kinetics at higher and lower exposure levels for most of the toxic dioxin congeners and of levels
in target tissues of concern. Environ Health Perspect 106(Suppl 2):737-742 (1998).
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Historical Review
Estimation of dose of polychlorinated
dibenzo-p-dioxins (PCDDs) and related
chemicals such as polychlorinated dibenzo-
furans (PCDFs) and polychlorinated
biphenyls (PCBs) is relatively straight-
forward in animal toxicology studies.
Dioxins are usually administered by gavage
or added to food. The percent ofabsorp-
tion is calculated from measurements of
the labeled compounds. In oily vehicles
absorption is quite high, approaching
100%, whereas absorption is usually less in
aqueous vehicles (1-7).
For wildlife, congener-specific dioxin
measurement in tissues, eggs, or environ-
mental media is now frequently performed
following discovery ofa toxic end point
such as eggshell thinning or malformations.
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Because synthetic chemicals other than
dioxins are also sometimes elevated, the
association between the individual chemicals
in a mixture and the toxic end point maybe
less clear than in laboratory studies using
specific dosing regimens in animal models
(8,9). For example, in addition to dioxins,
dibenzofurans, DDT, and DDT metabo-
lites, many PCB congeners are elevated in
tissue or egg specimens.
Until recently, human health studies
used only indirect measures to demonstrate
human exposure to dioxins. These indirect
measures were neither sensitive nor spe-
cific. Erythema, a reddish discoloration of
the skin, or chloracne, acne usually found
in a group ofworkers following exposure
to synthetic chlorinated organics, were the
most commonly observed signs indicating
exposure to chlorinated organics, including
dioxins. Although Herxheimer (10)
described chloracne in workers exposed to
organochlorines in the 19th century, it was
not established until 1957 that dioxins can
cause chloracne (11).
The first human dioxin measurements
were performed by Baughman in 1973 on
breast milk collected in 1970 and 1973
(12). Baughman compared 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) levels in
the milk ofVietnamese women from two
villages sprayed with Agent Orange conta-
minated with TCDD to those ofwomen
living in Massachusetts. TCDD was not
detected with the limits ofdetection avail-
able at that time in the milk ofthe women
from Massachusetts. Figure 1 shows women
from South Vietnam: these women had
TCDD levels that, when lipid adjusted,
were as high as 77 to 1850 ppt. The higher
levels are from milk collected in the last
year ofknown U.S. Air Force fixed-wing
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Figure 1. levels of TCDD in milk lipid from Southern
and Northern Vietnamese women collected from 1970
to 1988(13).
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Agent Orange spraying (1970); the lower
levels are from milk collected in 1973
(12-15). Figure 1 also shows TCDD levels
in milkspecimens collected in 1985 to 1988
from women living in Southern Vietnam
and those collected in 1988 from women
living in North Vietnam, where Agent
Orange was not sprayed. The TCDD level
is lower (2.1 ppt) for the milk ofwomen
from North Vietnam than it is for the milk
ofwomen from southern Vietnam (range
5.2-11 ppt). Archived Vietnamese milk
specimens, which had been stored at -70°C
at Harvard University (Cambridge, MA) by
RW Baughman and M Meselson, were
reanalyzed by JJ Ryan in the 1980s using
more refined modern techniques (16); the
findings were almost identical to those pre-
viouslyreportedbyBaughman (12).
In the late 1970s, Rappe et al. (17)
reported the presence of PCDFs in livers
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obtained from autopsies of two Japanese
Yusho (rice oil poisoning) victims. In 1982
Rappe et al. (18) reported homologue
groups of PCDDs and PCDFs in the
blood ofworkers exposed to 2,3,4,6-tetra-
chlorophenate and in the blood ofworkers
exposed to pentachlorophenol (PCP) or
PCP derivatives (18).
Subsequent studies found that parti-
tioning of dioxins varies between tissues
even when reported on a lipid-adjusted
basis (19). This complicates extrapolation
from dioxin blood, milk, or adipose tissue
levels to dioxin body burden. Figure 2,
using U.S. general population data, illus-
trates that blood lipid generally contains
the highest dioxin and dibenzofuran levels,
followed by adipose tissue lipid, then milk
lipid (20,21).
During the 1970s, environmental
measurement of dioxins became more
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the United States. (B) Comparison of PCDD, PCOF, and PCDD/PCDF calculated TCDD toxicity equivalent levels in
blood, adipose tissue, and milk from the United States (20).
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Figure 3. TCDD in adipose tissue (lipid 97%) of U.S. Vietnam veterans exposed to Agent Orange(13). &Calculated
using three 6-yearhalf-lives. bAdjusted for 1.4 increase in bodyfat.
common and was sometimes used to
estimate human exposure. In Seveso, Italy,
Zones A, B, and R were designated as
zones where high, medium, and slightly
above background levels ofTCDD, respec-
tively, were found in soil near the site ofa
1976 chemical factory explosion (22). Soil
levels rather than human tissue levels were
used to estimate exposure. Although ini-
tially useful, this approach did not take
into account variability in bioavailability,
differences in time ofpotential exposure,
or differences in kinetics ofabsorption and
elimination. Nor could it consider differ-
ent intake scenarios such as dermal expo-
sure and consumption ofvegetables grown
in home gardens potentially contaminated
with TCDD. An exception to the exclusive
measurement ofTCDD in environmental
samples was one autopsy performed with
TCDD analysis ofselected tissues from a
woman who died ofa presumably preexist-
ing cancer shortlyafter exposure to TCDD
in the Seveso incident. Adipose tissue had
the highest TCDD level, followed by pan-
creas (embedded in adipose tissue), then
liver (23).
In 1984 Gross et al. (24) published
findings of elevated TCDD in recently
obtained adipose tissue ofVietnam veterans
highly exposed to Agent Orange contami-
nated with TCDD. The veterans' exposure
occurred between 1962 and 1971; the heav-
iest Agent Orange spraying occurred
between 1967 and 1971 (24). Unlike some
previous human tissue sampling for dioxin
analyses, the adipose tissue was obtained by
biopsy from living exposed veterans.
Subsequent studies also found elevated
TCDD in a relatively small percent of
potentially exposed U.S. Vietnam veterans
(25-30). Figure 3 presents the elevated lev-
els ofTCDD found in adipose tissue from
six Massachusetts Vietnam veterans poten-
tially exposed to Agent Orange (12,25).
Also presented are estimates ofTCDD
levels atthe time ofexposure.
The heating of PCB and chlorinated
benzene transformer fluid during an electri-
cal fire on 5 February 1981 in Binghamton,
New York, produced a mixture ofPCBs,
dibenzofurans, and dioxins (found in soot,
surface wipes, and air) similar to that ofthe
Japanese Yusho and Taiwanese Yu-cheng
rice oil contaminations (31,32). Findings
ofelevated chlorinated dioxin and dibenzo-
furan congeners in the blood and adipose
tissue was reported for the first time in
1983 in exposed American workers. Also
noted for the first time was the presence of
dioxin and dibenzofuran congeners in the
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fat and blood of U.S. adults from the
general population, which served as the
comparison group (31,33). The work was
repeated and extended shortly thereafter
with improved specificity and sensitivity of
congener detection (34). Figure 4 shows
total measured PCDD and PCDF levels
from this study, which illustrates how the
findings of elevated PCDF or PCDD
congeners were used to document actual
exposure in some potentially exposed
Binghamton workers (12). Figure 5 shows
PCB levels reported as Aroclor 1254 in the
serum ofother workers (firefighters) shordy
after their exposure during the Binghamton
incident and 10 months later (35). By 10
months after exposure, the PCB levels in
the firefighters' serum were similar to those
ofthe general population. This illustrates
the rapid decrease in PCBs frequently
observed after acute exposure and demon-
strates the potential usefulness ofimmedi-
ate as well as serial blood testing after
exposure. Had PCB levels been measured
only once, 10 months after exposure, there
would have been no evidence ofelevated
levels, so erroneous conclusions regarding
exposure could easilyhave been made.
Epidemiology studies in the 1980s, and
even in the 1990s, rarely used tissue mea-
surement to estimate exposure to or dose of
dioxins. This omission caused difficulties in
exposure assessment. Two ofthe former
common assumptions were that the majority
ofVietnam veterans had exposure to Agent
Orange and its dioxin contaminant, and that
the general population did not have any
dioxin exposure. It was eventually realized
that both exposure assumptions were incor-
rect (19,29,36,37). The New Jersey,
Massachusetts, Michigan, and Centers for
Disease Control Agent Orange exposure
studies (25-30) showed that TCDD in
blood or adipose tissue was elevated above
U.S. background levels in only a small
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Figure 4. Measured PCDDs and PCDFs in adipose tissue
from exposed workers and controls in Binghamton,
New York, 2 years after a PCB transformer fire that
occurred on 5 February 1981 (13).
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Figure 5. Serial serum PCB levels in firefighters exposed in a PCB transformer fire in Binghamton, New York, 5
February 1981 (35). PCBs were reported as Aroclor 1254.
number ofthose Vietnam veterans studied
who were thought to have been exposed to
Agent Orange. It is now known that general
populations, at least ofpersons currently
living in industrial countries, have typical
patterns ofdioxins and dibenzofurans in
blood and other tissues, although there can
bevariations inpatterns between countries.
In the 1980s and early 1990s, exposure
assessment studies also found that levels of
dioxins are consistently higher in tissues
from the general population ofindustrial
countries and lower in persons from less
industrialized countries (20,38). Elevated
dioxin levels in heavily exposed workers
have been demonstrated as long as 34 years
after substantial exposure. Such extreme
persistence ofelevated dioxin levels demon-
strates that human tissue dioxin measure-
ment can be useful in documenting
exposure for at least three decades after
relatively high exposure (39,40). The asso-
ciation of PCDDs/PCDFs with relatively
recent chemical industry synthesis ofchlo-
rinated organics was also demonstrated by
the finding that levels of PCDDs/PCDFs
in tissues of ancient (100-400-year-old)
frozen Eskimo women fromAlaska are very
much lower than the levels currently found
in humans from industrial countries (41).
Despite demonstration ofthe usefulness
oftissue measurements and for a variety of
reasons, many recent otherwise sophisti-
cated epidemiology studies have not used
tissue measurements ofdioxins to estimate
exposure (42-46). On the other hand,
time employed in chemically contaminated
work areas can sometimes be used success-
fully as a surrogate for exposure or dose in
environmental epidemiology studies.
Some ofthe more recent epidemiology
studies concerning consequences ofexpo-
sure to dioxins began in the early 1990s to
include human tissue measurements as an
indicator ofbody burden (47-50). These
studies were usually ofcancer mortality and
were stimulated by the seminal work of
Hardell and colleagues (51-53). Hardell's
work pointed to a link between certain can-
cers and dioxin-contaminated herbicides
and chlorophenols. The studies include
reports ofincreased mortality rates for cer-
tain cancers and for ischemic cardiovascular
disease (51-53). They also include reports
ofincreased reproductive, developmental,
and endocrine alterations in the children of
mothers with higher general population
levels ofdioxins (49,50). The studies ofthe
Japanese Yusho rice oil incident, which
occurred in 1968, reported an increase in
birth defects, certain cancers, and cancer
mortality (54,55). In the almost identical
Taiwanese Yu-cheng rice oil poisoning,
which occurred in 1979, an increase in birth
defects and cognitive and behavioral impair-
ment was reported in children born to
mothers with Yu-cheng poisoning (56).
Initially both studies estimated dose bymea-
suring PCBs, PCDFs, and PCDDs in the
rice oil and estimating the amount ofrice oil
consumed. Later reports on Yusho and Yu-
cheng included human tissue measurement
ofPCBs and PCDDs/PCDFs (55).
Conclusions
Obtaining human tissues for dioxin
measurements was difficult initially because
adipose tissue or milk was necessary to pro-
vide a sufficient amount ofthe lipophilic
dioxins to measure. This required either
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minor surgery (usually under local anesthe-
sia) in the case ofthe fat tissue, or a nurs-
ing mother in the case of milk. With
improved analytic methods, blood has
become the tissue ofchoice. At first one
450-mi unit ofblood, usually 0.3 to 0.6%
lipid, was required for blood dioxin mea-
surement. At present as little as 50 to 100
ml of blood is needed for most general
population (from industrial countries)
dioxin analyses. However, obtaining 100
ml ofwhole blood requires a healthy adult
or multiple blood samples from a child or
less-than-healthy adult. Less blood is
needed when dioxin levels are elevated
above current background levels.
Dioxins have long half-lives ofelimin-
ation in humans and for the most part they
remain in human tissue in the parent form
rather than as metabolites. Therefore, direct
tissue dioxin measurement is useful for a
considerable time after exposure ifthe level
ofexposure was sufficiently high or the
exposure was prolonged. Knowledge of
half-life ofelimination for the 17 dioxin
and dibenzofuran congeners commonly
found in human tissue is critical in inter-
preting levels found from previous expo-
sure. TCDD is currently believed to have a
half-life of elimination in humans of
between 6 and 11 years (57-61), whereas
some higher chlorinated dibenzofurans
have been reported to have half-lives of
elimination between 1 and 5 years (62-65).
G6rski et al. (66) reported half-lives of
between 3 and 7 years for three PCDDs
and half-lives ofjust over 1 year for two
PCDFs. Recently, Flesch-Janys et al. (58)
reported half-lives for seven toxic PCDD
congeners and six toxic PCDF congeners.
They calculated that half-lives for dioxins
range from 3.7 years for 1,2,3,4,6,7,8-
heptachlorodibenzo-p-dioxin to 15.7 years
for 1,2,3,7,8-pentachlorodibenzo-p-dioxin.
For dibenzofurans, Flesch-Janys et al. (58)
calculated that half-lives range from 3.0
years for 1,2,3,4,6,7,8-heptachlorodi-
benzofuran to a surprising 19.6 years for
2,3,4,7,8-pentachlorodibenzofuran
(PeCDF). Ryan et al. (62) reported a more
rapid elimination ofthe Yusho-Yu-cheng
higher chlorinated PCDFs (PeCDF and
1,2,3,4,7,8-hexachlorodibenzofuran) a
short time after exposure when the levels
were higher, and slower rates ofelimination
later as levels declined. They report half-
lives of2.0 to 2.5 years closer to the time of
exposure when the PCDF levels were
higher and ofapproximately 10 years when
thelevels were lower (62).
Relatively high cost and a relatively
small number ofavailable laboratories with
demonstrated capability to accurately
report down to the low parts per trillion
background range have limited the use of
congener-specific and -sensitive dioxin
analyses in human health studies. Time for
completion ofanalyses is relatively long
compared to that required for other chemi-
cals. The World Health Organization has
certified fewer than 50 laboratories world-
wide for analysis of PCDDs/PCDFs in
human blood and milk. Some ofthese cer-
tified laboratories are government laborato-
ries not available for nongovernment work.
The charges of$2000 to $3000 per dioxin
analysis have now generally decreased to
just below $1000 each ifdone in quantity.
Recently the dioxin analyses have begun to
also indude some ofthe dioxinlike PCBs.
Although gas chromatography-mass
spectrometry (GC-MS) congener-specific
dioxin analysis is generally considered the
best available method ofestimating expo-
sure or dose, relatively fast and inexpensive
biologic or other screening tests have long
been sought. Many have been developed
but to date none are in general use. These
include tests designed to screen for aryl
hydrocarbon receptor-type chemicals, cur-
rently estimated to cost $200 to $400 per
test, with results obtained in less than 2
weeks. These screening tests include in
vitro enzyme induction, use ofmonoclonal
antibodies, and in vitro cell proliferation
(67-74). The goal ofsuch screening tests
is to permit human tissue or environmental
samples to be rapidly screened for evidence
ofelevated levels ofdioxinlike compounds.
Specimens with no evidence ofelevation
would be excluded from further analyses.
Specimens with evidence of elevation
would be analyzed by GC-MS for con-
gener-specific information. Such screening
could be useful after potential exposure of
large numbers of people. It could, for
example, facilitate screening following
potential exposure ofVietnamese, U.S.,
and other Vietnam veterans (from Korea,
Australia, and elsewhere) to Agent Orange.
Three million Americans served in
Vietnam during the Vietnam War, and
millions ofVietnamese lived or still live in
or near areas sprayed with Agent Orange.
Exposures to dioxins, dibenzofurans,
PCBs, and related chemicals can be ofcon-
cern for workers, persons living near con-
taminated sites, and fish-eaters consuming
dioxin-contaminated fish. At the present
time and with only a few exceptions
(75-78), most researchers consider GC-MS
thegoldstandard fordocumenting increased
dioxin dose.
It is hoped that all future health studies
will use the refined exposure estimates now
available. Such improved exposure assess-
ment should markedly improve epidemiol-
ogy studies relating to the health effects
caused bydioxins.
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